Stock Information
Protagonist Therapeutics Inc (PTGX)
Ticker Symbol: PTGX
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $6,487.88 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -2.0426
Revenue (TTM): $0.72 M
Dividend Yield: N/A%
ROE: -19.89%
Latest News
-
Citizens Maintains Market Outperform on Protagonist Therapeutics, Raises Price Target to $137
Wed, May 6, 2026 10:36 AM
-
Wedbush Maintains Outperform on Protagonist Therapeutics, Raises Price Target to $118
Wed, May 6, 2026 8:48 AM
-
Protagonist Therapeutics: Q1 Earnings Snapshot
Wed, May 6, 2026 3:12 AM
-
Protagonist Therapeutics Q1 EPS $0.05 Beats $(0.42) Estimate, Sales $56.368M Beat $16.273M Estimate
Tue, May 5, 2026 4:39 PM
-
Protagonist Reports First Quarter 2026 Financial Results and Provides Corporate Update
Tue, May 5, 2026 4:05 PM
Key Financials
Financial data not available
